AzTrials
AzTrials

StrokeNCT02935270

Examining Measurement of Behavioral Neglect Post Stroke

An observational study of Stroke and Hemispatial Neglect, run by Medical University of South Carolina at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to examine measurement of unilateral neglect post stroke. Although a number of clinical assessments are used to measure neglect, it is unclear whether items from some of the most commonly used assessments are able to effectively and comprehensively measure neglect. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke, Hemispatial Neglect
How many people
55 participants
Where
1 siteUnited States
Study dates
Jan 2016to 21 Feb 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Stroke survivors

Who may be able to join

  • Unilateral hemispheric stroke
  • 18 years or older

Who cannot join

  • Severe aphasia
  • Inability to follow 2-step directions
  • Presence of other neurological disease that may impair vision or perception during performance of evaluation procedures

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Medical University of South Carolina

    Charleston, South Carolina, 29425

Other trials in United States

About this study

The purpose of this study is to examine measurement of unilateral neglect post stroke. Although a number of clinical assessments are used to measure neglect, it is unclear whether items from some of the most commonly used assessments are able to effectively and comprehensively measure neglect. This study will determine whether these assessments measure different aspects of neglect and whether items from various neglect assessments can be combined to more effectively measure neglect.

Read the detailed description

Many individuals have difficulty attending to the affected side of their body or to the affected side of space after stroke (unilateral neglect). Although a number of clinical assessments are used to measure this inattention, it is unclear whether items from some of the most commonly used assessments are able to effectively and comprehensively measure inattention. Clinical assessments provide critical information to clinicians and researchers and are used to inform treatment and document patient progress. Therefore, it is important that investigators more closely examine these existing assessments.

Individuals who demonstrate impaired attention to the affected side after stroke also have greater motor impairment than individuals who do not have impaired attention, but investigators do not know how inattention affects reaching movements using the impaired arm. This study will examine various methods used to assess inattention to the affected side after stroke and also examine how inattention affects reaching movements of the impaired arm.

Keywords
Stroke, Neglect, Rehabilitation
Medical subject headings
Stroke, Perceptual Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02935270
Study groupRoleWhat they receive
Stroke SurvivorsIndividuals who have experienced a unilateral hemispheric stroke

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Catherine Bergego Scale

    Measured: One-time assessment scheduled over 1-2 days

  2. Behavioral Inattention Test

    Measured: One-time assessment scheduled over 1-2 days

  3. Naturalistic Action Test

    Measured: One-time assessment scheduled over 1-2 days

  4. Virtual Reality Lateralized Attention Test

    Measured: One-time assessment scheduled over 1-2 days

  5. Kinematic Assessment of Arm Movement

    Measured: One-time assessment scheduled over 1-2 days

Secondary outcomes (1)
  1. Arm Use measured by Accelerometers

    Accelerometers will be issued on the first assessment day. Participants will wear accelerometers for 3 days.

    Measured: One-time assessment scheduled over 3 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Oct 2016 (estimated)
  2. Study startJan 2016
  3. Primary completion21 Feb 2020
  4. Study completion21 Feb 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
55 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02935270
Sponsor's protocol ID
PR00044531
Status last verified
Nov 2022
First submitted
12 Oct 2016
Last updated
25 Nov 2022
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Grattan ES, Woodbury ML. Do Neglect Assessments Detect Neglect Differently? Am J Occup Ther. 2017 May/Jun;71(3):7103190050p1-7103190050p9. doi: 10.5014/ajot.2017.025015.

    PubMed 28422631

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke and Hemispatial Neglect, run by Medical University of South Carolina at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Catherine Bergego Scale (time frame: One-time assessment scheduled over 1-2 days). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02935270, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT02935270 | AzTrials